Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases-Reference-Cited by-同舟云学术

Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases

Published:2022-03-29 Issue:3 Volume:32 Page:205-210
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ingen-Housz-Oro Saskia,Milpied Brigitte,Badrignans Marine,Carrera Cristina,Elshot Yannick S.,Bensaid Benoit,Segura Sonia,Apalla Zoé,Markova Alina,Staumont-Sallé Delphine,Marti-Marti Ignasi,Giavedoni Priscila,Chua Ser-Ling,Darrigade Anne-Sophie,Dezoteux Frédéric,Starace Michela,Torre Ana Clara,Riganti Julia,de Prost Nicolas,Lebrun-Vignes Bénédicte,Bauvin Olivia,Walsh Sarah,Ortonne Nicolas,French Lars E.,Sibaud Vincent

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference18 articles.

1. European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement.;Apalla;J Eur Acad Dermatol Venereol,2022

2. Immune checkpoint inhibitor-related dermatologic adverse events.;Geisler;J Am Acad Dermatol,2020

3. Toxic epidermal necrolysis-like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma.;Nayar;J Immunother,2016

4. Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.;Hwang;J Oncol Pharm Pract,2019

5. Toxic epidermal necrolysis associated with pembrolizumab.;Cai;J Oncol Pharm Pract,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nivolumab-induced SJS/TEN-like reaction;Archives of Dermatological Research;2024-05-25

2. The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases;American Journal of Clinical Dermatology;2024-05-20

3. IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation;JAAD Case Reports;2024-05

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. Immune checkpoint inhibitor‐induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications;The Journal of Dermatology;2023-11-30